Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan/Clofarabine RIC for Allogeneic Stem Cell Transplant
NCT01643668Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2012
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), sponsored by Massachusetts General Hospital. Started Jul 2012; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01643668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01643668.